Phantom limb phrase has always been used to define illusion of presence of a limb after it has been amputated.[@bib1] Phantom limb complex includes 3 different terms: phantom sensation (PS), stump pain (SP), and phantom limb pain (PLP).[@bib2] Although PS and SP are considered normal condition, PLP is not evaluated as normal status. Cerebral changes, as well as peripheral and spinal factors, have been suggested as pathophysiological factors of PLP. Peripheral nerve damage causes increase in ectopic activity and loss of inhibitory control at the dorsal horn. Furthermore, PLP corresponds to maladaptive reorganization of the thalamus and body representations in somatosensory and motor cortices.[@bib3]

Incidence of PLP ranges from as low as 2%--80%. PLP has been described as shooting, boring, squeezing, throbbing, and burning sensations.[@bib4] PLP begins immediately following amputation, within the first 24 h, for about half of patients, and within a week for another 25%.[@bib2], [@bib5] It has been reported that PLP persists over time.[@bib6], [@bib7]

Occurrence of PLP seems to be independent of age in adults, as well as gender, level, and side of amputation.[@bib2] PLP generally occurs distally to missing limb.[@bib6], [@bib7], [@bib8] There are conflicting data regarding relationship between level of amputation and presence of PLP. Some studies emphasize that there was no association found between PLP and level of amputation.[@bib6], [@bib7] In contrast, Dijkstra et al have reported that PLP was more common in proximal site of limb.[@bib9] Aim of the current study was to investigate relationship between level of amputation and occurrence of phantom limb, and whether any change was observed 6 months after amputation in patients who did not have any treatment for phantom limb.

Patients and methods {#sec1}
====================

Design of this hospital-based study was combination of retrospective review and cross-sectional interview. Clinical trial was performed at the Department of Physical Medicine and Rehabilitation and Department of Orthopedics of Cukurova University Faculty of Medicine. Study protocol was approved by the institutional review board of Cukurova University.

The patients included in the study had amputation of lower limb extremity between 6 months and 3 years before interview. Hospital database records of computer-based pre- and post-operative files from years 2010 through 2012 were analyzed and interviews were conducted with the patients who fulfilled criteria. Patients were evaluated in both early postoperative period (EPP) and 6 months after surgery (ASM). Data related to amputation: amputation date, level, cause, PS, PLP, SP, components of PLP (i.e., intensity of pain and number of attacks) were recorded based on information obtained from the patients and hospital files. EPP data were obtained from hospital database and patients\' preoperative and postoperative files. ASM data were obtained from face-to-face interviews.

Patients were classified into 3 groups according to amputation level. Group I included those patients with hip disarticulation to knee disarticulation (including knee disarticulation), Group II comprised patients with transtibial amputation (below knee to ankle, including ankle disarticulation), and Group III was made up of patients with below ankle to toe amputation. Patients were excluded from the study if there were missing data concerning amputation or records of follow-up period. In addition, patients were excluded if there was systemic malignancy or musculoskeletal malignancy, patient was in active chemotherapy treatment, receiving analgesic medication, there were severe psychological problems, patient was younger than 18 years of age, or patient received medical treatment for PLP.

All analyses were performed using SPSS version 20.0 statistical software (IBM Corp., Armonk, NY, USA). Categorical variables were expressed as numbers and percentages, and continuous variables were summarized as mean and standard deviation, or as median and minimum-maximum, where appropriate. Chi-square test was used to compare categorical variables between groups. For comparison of continuous variables between 2 groups, Student\'s t-test was used. For comparison of 2 related (paired) continuous variables, Wilcoxon signed-rank test was used. For comparison of more than 2 groups, one-way analysis of variance or Kruskal--Wallis test was used, depending on whether or not statistical hypothesis was fulfilled. For normally distributed data regarding homogeneity of variances, Bonferroni, Scheffe, and Tamhane tests were used for multiple comparisons of groups. For non-normally distributed data, Bonferroni-adjusted Mann Whitney U-test was used for multiple comparisons of groups. p value of \<0.05 was considered statistically significant.

Results {#sec2}
=======

Records of 317 patients with lower limb amputation were evaluated. In all, 101 patients were included in the study. Thirteen of the original 317 patients had died, hospital records of 51 patients were inadequate, ASM interview could not performed with 52 patients due to contact failure, and 100 patients were excluded as result of treatment for PLP.

Group I, above-knee amputation (including knee disarticulation) comprised 25 patients; Group II, transtibial amputation to ankle (including ankle disarticulation) consisted of 41 patients; and Group III, below ankle to toe amputation was made up of 35 patients. Although there was no significant difference in terms of age or gender among 3 groups (p = 0.088, p = 0.632, respectively), mean age of patients in Group I was younger than other groups ([Table 1](#tbl1){ref-type="table"}). There was no significant difference regarding preoperative visual analog scale (VAS) scores between 3 groups (p = 0.803; [Table 1](#tbl1){ref-type="table"}). Additional demographic and baseline clinical data are provided in [Table 1](#tbl1){ref-type="table"}.Table 1Patient demographic and clinical data.Table 1Group I (n = 25)Group II (n = 41)Group III (n = 35)pAge (mean) (min/max) (SD)55,9 (18/73) (19.4)58.6 (18/85) (13.7)58.7 (21/80) (13.7)0.088Gender (M/F)19/633/826/90.632Occupation (n) Laborer1139 Retired327 Office worker742 Craftsman8149 Housewife366 Other325Reason for amputation (n) Trauma13177 DM21225 Vascular disease651 Cancer420 Infection031 Other021Method of amputation Hip disarticulation2 Transfemoral15 Knee disarticulation8 Transtibial39 Ankle disarticulation2 Chopart17 Lisfranc17 Toe1Patients with preoperative pain (n)10/2523/419/35Preoperative VAS (mean) (SD)5.5 (1.2)5.5 (1.7)5.2 (1.8)0.803[^1][^2]

SP was observed in all patients at EPP, and there were no significant difference in number of patients with SP at EPP and ASM assessments. Statistically significant differences were found for SP intensity between all groups at EPP (p \< 0.001). This difference was due to Group I, as mean VAS score at EPP in Group I was higher than other groups. However, this difference was not seen at ASM assessment (p = 0.242; [Table 2](#tbl2){ref-type="table"}).Table 2Stump pain frequency and intensity in 3 patient groups.Table 2Group I (n = 25)Group II (n = 41)Group III (n = 35)pStump pain (EPP) (n)25/2541/4135/35Stump pain (ASM) (n)13/256/398/37Stump pain VAS score (EPP) (SD)7.12 (0.73)5.79 (1.28)5.54 (1.41)\<0.001Stump pain VAS score (ASM) (SD)3.46 (1.4)4.20 (1.30)3.44 (1.01)0.242[^3][^4]

All patients in Group I (n = 25) had PLP at EPP, while 35 of 41 patients in Group II, and 31 of 35 patients in Group III had PLP at EPP. No significant difference was found between number of patients and PLP at EPP (p = 0.112; [Table 3](#tbl3){ref-type="table"}). Approximately 50% decrease in number of patients with PLP was observed in all groups at ASM. There was significant difference in PLP VAS scores among 3 groups at EPP (p = 0.021), with Group I scoring higher than other groups. This significance was due to difference between Group I and Group II (p = 0.038). However, this difference did not persist at ASM assessment (p = 0.580). Number of PLP attacks was higher in Group I than other groups and there were statistically significant differences between all groups at EPP (p = 0.001; [Table 3](#tbl3){ref-type="table"}). Total of 24 of 25 patients in Group I had PLP all during the day. This difference was not present at ASM (p = 0.495; [Table 3](#tbl3){ref-type="table"}).Table 3Phantom pain frequency and intensity in 3 patient groups.Table 3Group I (n = 25)Group II (n = 41)Group III (n = 35)pPhantom pain (EPP) (n)2535310.112Phantom pain (ASM) (n)1716120.201Phantom pain VAS score (EPP) (SD)7.12 (0.83)6.51 (1.03)6.90 (0.70)0.036**Pı-ıı**0.038**Pı-ııı**0.999**Pıı-ııı**0.198Phantom pain VAS score (ASM) (SD)3.79 (0.90)3.79 (1.04)3.44 (1.00)0.580Phantom pain attack (EPP) (n) Permanent2418190.001 Everyday, on and off11712 Once in 3 days000 Once a week000 Once in 10 days000 Once in 15 days000 Once a month000Phantom pain attack (ASM) (n) Permanent0000.495 Everyday on and off000 Once in 3 days021 Once a week223 Once in 10 days352 Once in 15 days663 Once a month613[^5][^6]

All patients had PS at EPP and there were no statistically significant differences between groups at ASM assessment (p = 0.627; [Table 4](#tbl4){ref-type="table"}).Table 4Number of patients reporting phantom sensation in 3 patient groups.Table 4Group I (n = 25)Group II (n = 41)Group III (n = 35)pPhantom sensation (EPP) (n)254135Phantom sensation (ASM) (n)2131300.627[^7][^8]

Discussion {#sec3}
==========

Phantom limb complex includes PLP, PS, and residual limb pain. This phenomenon has been known since ancient times. It has been suggested that phantom limb occurs in between 90% and 98% of patients after amputation.[@bib10] Pathophysiological background of phantom limb-related phenomena, especially PLP, is still unclear. Some hypotheses have been suggested to account for its development, including peripheral generators and changes to spinal cord excitability or brain plasticity.[@bib1]

In this study, we aimed to investigate prognosis of patients with phantom limb who had not had any therapeutic intervention for PLP. We found that patients with higher pain intensity scores at EPP had higher level of amputation, but all patients had SP at EPP. This was an expected condition at EPP. However, there was no SP in majority of patients at ASM evaluation. Although VAS score of Group I was higher than other groups at EPP, it was similar for all 3 groups at ASM. Most common etiology of amputation in Group I was trauma, and this may account for higher initial VAS score. In a review, it was reported that SP was quite frequent at EPP, which was consistent with our study, but persisting pain was reported in 5%--10% of patients with SP, and it was thought might get worse with time. Authors also suggested relationship between SP onset and prognosis with etiology of amputation.[@bib2] In another report, the authors indicated SP occurrence rate of 74%, which was lower than that seen in our study.[@bib11] Patients, especially those who have above-knee amputation, should be informed about prognosis of SP. Furthermore, physicians should be aware of this condition and arrange treatment plan in order to prevent or treat SP.

PS is accepted as generally normal condition.[@bib3] Casale et al reported that rate of PS was 90% after 6 months and 60% 1 year after lower limb amputation.[@bib1] Results of this study at ASM were consistent with the findings of our study. Nearly 80% of patients in the current study had PS at ASM.

PLP was first introduced by Ambrose Pare, who was a military surgeon in the mid-16th century.[@bib5] Since that time, numerous studies have been performed on epidemiology, pathophysiology, and clinical outcomes of PLP. Despite the difficulties, theories on pathophysiological mechanisms of PLP are growing. Central sensitization and peripheral factors, including ectopic discharge from neuroma, wound infection, osteomyelitis, and poor prosthetic fit, are generally suggested as primary causes. Cortical reorganization has been reported to be responsible for peripheral and central changes in chronic PLP. Cortical reorganization affects perceptual, motor, and autonomic systems, which are related to PLP. In addition, psychological factors have also been reported to evoke and modulate PLP.[@bib12]

PLP consists of 4 domains, including intensity, frequency of episodes, duration of each episode, and description of pain.[@bib13] We only evaluated intensity and frequency of episodes in the current study as result of retrospective design. There are many studies regarding prognosis, characteristics, and clinical features of PLP in the literature. It has been reported that postamputation period and cause of amputation were important predictive factors for prognosis of PLP, yet it was also reported that there was no difference in development of PLP between patients with and without diabetes mellitus (DM).[@bib14] More severe PLP generally occurs due to peripheral vascular disease after amputation. Intensity of PLP has been reported to decrease after 6 months.[@bib15], [@bib16], [@bib17] This result is consistent with the present study. Etiology of amputation has been reported to have no effect on PLP.[@bib2], [@bib5] Unfortunately, we did not evaluate influence of etiology on PLP in present study.

There have been conflicting results regarding association between preoperative pain and PLP.[@bib5], [@bib6], [@bib18], [@bib19] There was no difference between 3 groups in the current study with regard to preamputation pain. Results of our study demonstrate no relationship between preoperative pain and PLP.

Conflicting results regarding correlation between level of amputation and PLP have been reported in the literature.[@bib13], [@bib6], [@bib20], [@bib21] We found statistically significant difference in PLP between all groups, but in one-by-one analysis significant difference was found only between Groups I and II. However, pain scores decreased in all groups at ASM, and no significant difference was found at that point. Also, it was observed that pain attacks were more intense in all groups at EPP. It was reported that painful attacks decreased over time.[@bib2] These results indicated that above-knee amputation and distal amputation were predictive factors for PLP. Furthermore, additional factors may trigger PLP, such as weather changes, stump massage, and stress, and these factors may complicate studies of PLP.[@bib2], [@bib22] Patients should also be informed of effects of psychological factors on development of PLP, especially patients with above-knee and distal amputation.

Limitations of our study include relatively small number of patients in all groups; lack of etiological comparison because primary etiology was trauma in Group I, while DM was most common cause in group III; and retrospective design of study, which meant many patients were excluded due to insufficient data.

In conclusion, we found that intensity and attacks of untreated PLP were higher at EPP in patients who had above-knee amputation. There were no significant differences in long-term follow-up between groups. SP and PS were observed in all patients at EPP. SP intensity was higher in patients with above-knee amputation at EPP. Further studies with large sample size and with long-term follow-up assessments could provide new data about prognosis and clinical features of PLP.
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[^1]: Group I: Hip disarticulation to knee disarticulation (including knee disarticulation); Group II: Transtibial amputation (below knee to ankle, including ankle disarticulation); Group III: Below ankle to toe amputation.

[^2]: DM: Diabetes mellitus; VAS: visual analog scale.

[^3]: Group I: Hip disarticulation to knee disarticulation (including knee disarticulation); Group II: Transtibial amputation (below knee to ankle, including ankle disarticulation); Group III: Below ankle to toe amputation.

[^4]: ASM: Six months postamputation; EPP: Early postoperative period; VAS: visual analog scale.

[^5]: Group I: Hip disarticulation to knee disarticulation (including knee disarticulation); Group II: Transtibial amputation (below knee to ankle, including ankle disarticulation); Group III: Below ankle to toe amputation.

[^6]: ASM: Six months postamputation; EPP: Early postoperative period; VAS: visual analog scale.

[^7]: Group I: Hip disarticulation to knee disarticulation (including knee disarticulation); Group II: Transtibial amputation (below knee to ankle, including ankle disarticulation); Group III: Below ankle to toe amputation.

[^8]: ASM: Six months postamputation; EPP: Early postoperative period.
